Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation (Q59313024)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation |
article |
Statements
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) (English)
Christopher B. Granger
Christopher B Granger
Renato D Lopes
John H Alexander
Marten Rosenqvist
Stefan H Hohnloser
Steen Husted
Veli Pekka Harjola
Sana M Al-Khatib
ARISTOTLE Committees and Investigators
Puneet Mohan
Greg Flaker
Jun Zhu
David Garcia
Jozef Bartunek
Dragos Vinereanu
Antonio G Hermosillo
6 November 2013